Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,138,100
-$307,831 QoQ
Shares Held
7,262
-23.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#582
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Welch Group, LLC holds $262,604,589 across 9 Drug Manufacturers - General names. NVS ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
371,366 | $93,450,540 | |
| 2 | JNJ |
Johnson & Johnson
|
356,484 | $90,536,241 | |
| 3 | PFE |
Pfizer Inc
|
2,194,625 | $52,846,570 | |
| 4 | LLY |
ELI LILLY & Co
|
15,064 | $18,068,215 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,231 | $4,784,183 | |
| 6 | NVS |
Novartis AG
This page
|
7,262 | $1,138,100 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,167 | $758,682 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,699 | $593,671 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,138,100 | 7,262 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,445,931 | 9,466 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,331,272 | 9,656 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,213,919 | 9,466 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,145,480 | 9,466 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,053,040 | 9,446 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $920,357 | 9,458 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,132,026 | 9,842 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,088,659 | 10,226 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $989,160 | 10,226 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $1,088,658 | 10,782 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,110,783 | 10,905 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,190,031 | 11,793 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,084,956 | 11,793 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $1,189,248 | 13,109 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,030,467 | 13,557 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,145,973 | 13,557 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,311,072 | 14,941 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,452,439 | 16,605 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $2,058,893 | 25,176 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $34,653,955 | 379,811 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $31,094,546 | 363,764 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $33,960,805 | 359,640 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $30,863,321 | 354,914 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $30,169,768 | 345,429 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $28,240,609 | 342,518 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||